原著 |
|
|
|
|
UCP2 rs659366位点多态性与结直肠癌术后患者生存结局的关系 |
蒋滟蕲1( ),杨雅兰1,杨婷1,李玥伶2,陈莉玲3,燕锦4,杨艳芳1,*( ) |
1. 四川大学华西公共卫生学院流行病与卫生统计学系, 四川 成都 610041 2. 成都市疾病预防控制中心传染病防治科, 四川 成都 610041 3. 重庆市疾病预防控制中心慢性非传染性疾病预防控制所, 重庆 400042 4. 四川省肿瘤医院肠道外科, 四川 成都 610041 |
|
Association of UCP2 rs659366 polymorphisms with the outcomes of patients after surgery for colorectal cancer |
JIANG Yanqi1( ),YANG Yalan1,YANG Ting1,LI Yueling2,CHEN Liling3,YAN Jin4,YANG Yanfang1,*( ) |
1. Department of Epidemiology and Biostatistics, West China School of Public Health, Sichuan University, Chengdu 610041, China 2. Department of Infectious Disease Control and Prevention, Chengdu Center for Disease Control and Prevention, Chengdu 610041, China 3. Institute for Chronic Non-communicable Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Chongqing 400042, China 4. Department of Intestinal Surgery, Sichuan Cancer Hospital, Chengdu 610041, China |
引用本文:
蒋滟蕲,杨雅兰,杨婷,李玥伶,陈莉玲,燕锦,杨艳芳. UCP2 rs659366位点多态性与结直肠癌术后患者生存结局的关系[J]. 浙江大学学报(医学版), 2018, 47(2): 143-149.
JIANG Yanqi,YANG Yalan,YANG Ting,LI Yueling,CHEN Liling,YAN Jin,YANG Yanfang. Association of UCP2 rs659366 polymorphisms with the outcomes of patients after surgery for colorectal cancer. J Zhejiang Univ (Med Sci), 2018, 47(2): 143-149.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2018.04.06
或
http://www.zjujournals.com/med/CN/Y2018/V47/I2/143
|
1 |
FERLAY J , SOERJOMATARAM I , DIKSHIT R et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136 (5): E359- E386
doi: 10.1002/ijc.29210
|
2 |
CHEN W , ZHENG R , BAADE P D et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66 (2): 115- 132
doi: 10.3322/caac.21338
|
3 |
BOSETTI C , LEVI F , ROSATO V et al. Recent trends in colorectal cancer mortality in Europe[J]. Int J Cancer, 2011, 129 (1): 180- 191
doi: 10.1002/ijc.v129.1
|
4 |
GUO P , HUANG Z L , YU P et al. Trends in cancer mortality in China:an update[J]. Ann Oncol, 2012, 23 (10): 2755- 2762
doi: 10.1093/annonc/mds069
|
5 |
CUEZVA J M , KRAJEWSKA M , DE HEREDIA M L et al. The bioenergetic signature of cancer:a marker of tumor progression[J]. Cancer Res, 2002, 62 (22): 6674- 6681
|
6 |
DERDAK Z , MARK N M , BELDI G et al. The mitochondrial uncoupling protein-2 promotes chemo-resistance in cancer cells[J]. Cancer Res, 2008, 68 (8): 2813- 2819
doi: 10.1158/0008-5472.CAN-08-0053
|
7 |
HEIDARI J , AKRAMI S M , HESHMAT R et al. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population:a case control study[J]. Arch Iran Med, 2010, 13 (5): 384- 390
|
8 |
YAHAGI M , OKABAYASHI K , HASEGAWA H et al. The worse prognosis of right-sided compared with left-sided colon cancers:a systematic review and meta-analysis[J]. J Gastrointest Surg, 2016, 20 (3): 648- 655
doi: 10.1007/s11605-015-3026-6
|
9 |
JESS T , RUNGOE C , PEYRIN-BIROULET L . Risk of colorectal cancer in patients with ulcerative colitis:a meta-analysis of population-based cohort studies[J]. Clin Gastroenterol Hepatol, 2012, 10 (6): 639- 645
doi: 10.1016/j.cgh.2012.01.010
|
10 |
TSAI P L , SU W J , LEUNG W H et al. Neutrophil-lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer:a systematic review and meta-analysis[J]. J Cancer Res Ther, 2016, 12 (2): 582- 589
doi: 10.4103/0973-1482.144356
|
11 |
ATSUSHI I , MITSUYOSHI O , KAZUYA Y et al. Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer:a multicenter retrospective cohort study[J]. World J Gastroenterol, 2016, 22 (22): 5237- 5245
doi: 10.3748/wjg.v22.i22.5237
|
12 |
SASAKI T , ITO Y , OHUE M et al. Postoperative chemoradiotherapy after local resection for high-risk T1 to T2 low rectal cancer:results of a single-arm, multi-institutional, phase Ⅱ clinical trial[J]. Dis Colon Rectum, 2017, 60 (9): 914- 921
doi: 10.1097/DCR.0000000000000870
|
13 |
WU Q , WEI M , YE Z et al. Laparoscopic colectomy versus open colectomy for treatment of transverse colon cancer:a systematic review and meta-analysis[J]. J Laparoendosc Adv Surg Tech A, 2017, 27 (10): 1038- 1050
doi: 10.1089/lap.2017.0031
|
14 |
KREMPLER F , ESTERBAUER H , WEITGASSER R et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans[J]. Diabetes, 2002, 51 (11): 3331- 3335
doi: 10.2337/diabetes.51.11.3331
|
15 |
SESTI G , CARDELLINI M , MARINIM A et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects[J]. Diabetes, 2003, 52 (5): 1280- 1283
doi: 10.2337/diabetes.52.5.1280
|
16 |
WANG H , CHU W S , LU T et al. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion[J]. Am J Physiol Endocrinol Metab, 2004, 286 (1): E1- E7
doi: 10.1152/ajpendo.00231.2003
|
17 |
HORIMOTO M , RESNICK M B , KONKIN T A et al. Expression of uncoupling protein-2 in human colon cancer[J]. Clin Cancer Res, 2004, 10 (18 Pt 1): 6203- 6207
|
18 |
HU X, YUAN P, YAN J, et al. Gene polymorphisms of ADIPOQ +45T>G, UCP2-866G>A, and FABP2 Ala54Thr on the risk of colorectal cancer: a matched case-control study[J/OL]. PLoS One, 2013, 8(6): e67275.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|